TCL Archive Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete. June 25, 2004
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure October 23, 1998